Naples asks about Jovic

first_imgLuka Jovic has finished in the sights of Naples. The Azzurri, in the next course, could quite change the face of their forward, at the end of a cycle. If Dries Mertens is one step away from renewing his contract that expires in June, José Maria Callejón and Arkadiusz Milik could say goodbye. The motrileño can leave for free in June (although his agent, on Friday, said the club wants to renew him), while the Polish has another contract year left. Southerners have a very good relationship with their representative, Fali Ramadani, and already have four players from their team (Kalidou Koulibaly, Nikola Maksimovic, Diego Demme and Kévin Malcuit). In the past months they have already taken information on the forward, who If I had to leave Madrid, I would look forward to an adventure under Vesuvius. The Real Madrid, meanwhile, I would rather not part after just one season of such a young soccer player, which cost around 60 million and, in this course, barely had prominence. Yes, whites would certainly consider a transfer feasible (which Naples would hardly accept) or a transfer with repurchase option. Obviously, everything will depend on the fate of Milik, who also likes Atlético de Madrid: if he Naples It doesn’t sell you, you can’t go for another striker. 18 Negotiations to prolong the link of the former Ajax have not come to fruition, and for now the idea of ​​separating after four years after his arrival seems the most likely. To replace him, Of Laurentiis I would like to get the services of a young tip, but guarantees, Y Luka Jovic It is one of the names you are considering.last_img read more

Insurer Sues Medtronic Over BoneGrowth Drug

first_img This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Humana Inc. alleges the device maker violated federal racketeering statutes by conspiring with prominent physicians to promote unapproved uses of the drug, reports The Wall Street Journal. Meanwhile, Ventas, the nation’s biggest health care real estate investment trust, said Monday it had agreed to acquire the American Realty Capital Healthcare Trust for $2.6 billion.The Wall Street Journal: Humana Files RICO Claim Over Medtronic Bone DrugHealth insurer Humana Inc. is alleging that medical-device maker Medtronic Inc. violated the federal racketeering statute by conspiring with prominent physicians to promote unapproved uses of its bone-growth drug, according to a lawsuit Humana filed in federal court last week. Humana alleges that Medtronic paid $210 million to prominent physicians who advocated the drug’s use in certain neck and spine surgeries that hadn’t been approved by the U.S. Food and Drug Administration, according to Humana’s complaint (Walker, 6/2).The New York Times: Ventas To Buy American Realty Capital Healthcare For $2.6 BillionVentas, the nation’s biggest health care real estate investment trust, said on Monday that it had agreed to acquire the American Realty Capital Healthcare Trust for $2.6 billion in stock and cash. At $11.33 a share, the offer is 14 percent above the Friday closing stock of the company, known as A.R.C. Healthcare (6/2). Insurer Sues Medtronic Over Bone-Growth Druglast_img read more